Cargando…
A Review of MAL-PDT for the Treatment Strategy of Actinic Keratosis: Broader Clinical Perspectives Beyond the Data and Guideline Recommendations
Methyl aminolevulinate (MAL) is a topical compound approved for use with photodynamic therapy (PDT) for the treatment of actinic keratosis (AK) and field cancerization in certain countries. There exists a high burden of disease for patients with AK: repeated treatments are required, there is a known...
Autores principales: | Szeimies, Rolf-Markus, Dirschka, Thomas, Fargnoli, Maria Concetta, Gilaberte, Yolanda, Hædersdal, Merete, Chavda, Rajeev, Calzavara-Pinton, Piergiacomo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Healthcare
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10307748/ https://www.ncbi.nlm.nih.gov/pubmed/37300793 http://dx.doi.org/10.1007/s13555-023-00936-w |
Ejemplares similares
-
Expert Recommendations on Facilitating Personalized Approaches to Long-term Management of Actinic Keratosis: The Personalizing Actinic Keratosis Treatment (PAKT) Project
por: MORTON, Colin, et al.
Publicado: (2023) -
Cryotherapy for Actinic Keratosis: Basic Principles and Literature Review
por: Arisi, Mariachiara, et al.
Publicado: (2022) -
Efficacy Endpoints in Clinical Trials in Actinic Keratosis
por: Skov, Torsten, et al.
Publicado: (2018) -
Use of Lesion Response Rate in Actinic Keratosis Trials
por: Szeimies, Rolf-Markus, et al.
Publicado: (2016) -
The medical treatment of the actinic keratosis and the skin tumours: photodynamic therapy (PDT)
por: Provenzano, E, et al.
Publicado: (2010)